Entry Detail



General Information

Database ID:exR0753604
RNA Name:AC010642.2
RNA Type:lncRNA
Chromosome:chr19
Starnd:-
Coordinate:
Start Site(bp):58309727End Site(bp):58327248
External Links:ENSG00000283103



Disease Information

Disease Name:Glioblastoma Multiforme
Disease Category:Cancers
MeSH ID:D005909
Type:Neoplasms/Neoplasms, Glandular and Epithelial
Alias:Glioblastoma//Glioblastomas//Astrocytoma, Grade IV//Astrocytomas, Grade IV//Grade IV Astrocytoma//Grade IV Astrocytomas//Glioblastoma Multiforme//Giant Cell Glioblastoma//Giant Cell Glioblastomas//Glioblastoma, Giant Cell//Glioblastomas, Giant Cell



Expression Detail

GEO ID:GSE106804
Description:Engineered Nanointerfaces for Microfluidic Isolation and Molecular Profiling of Tumor-specific Extracellular Vesicles
Experimental Design:Cancer vs Control
Case Disease Type:Glioblastoma Multiforme
Case Disease SubType:NA
Case Sample:Glioblastoma Multiforme
Control Sample:Healthy
Number of Case:13
Number of Control:6
Number of Samples:19





Regulatory Relationship

mRNA targets:
Gene SymbolChromosomeStart Site(bp)End Site(bp)Strand
ABCF1
chr6
30571393
30597179
+
CSTF1
chr20
56392371
56406362
+
DPH1
chr17
2030110
2043430
+
EDARADD
chr1
236348257
236502915
+
FAU
chr11
65120630
65122177
-
GNAS
chr20
58839718
58911192
+
HSP90AB1
chr6
44246166
44253888
+
LAMB1
chr7
107923799
108003187
-
LCLAT1
chr2
30447226
30644225
+
MRPL37
chr1
54184041
54225464
+
OVCA2
chr17
2042022
2043425
+
PHB2
chr12
6965327
6970753
-
RCAN3
chr1
24502351
24541040
+
RPL15
chr3
23916545
23924374
+
RPLP0
chr12
120196699
120201235
-
RPS14
chr5
150442635
150449739
-
TM6SF1
chr15
83107572
83144854
+
ZDHHC17
chr12
76763588
76853696
+
miRNA targets:NA
circRNA targets:NA
lncRNA targets:NA
Display:



Experiment Detail

GEO ID:NA
Sample Source:NA
Source Fraction:NA
Platform:NA
Method:NA
Num of detected RNA Type:NA
Num of detected RNAs of this Type:NA
Sample treatment protocol:NA
RNA Extract protocol:NA
RNA library preparation protocol:NA



Reference

PMID:29330365
Title:Engineered nanointerfaces for microfluidic isolation and molecular profiling of tumor-specific extracellular vesicles.
Author:Re¨¢tegui E, van der Vos KE, Lai CP, Zeinali M, Atai NA, Aldikacti B, Floyd FP Jr, H Khankhel A, Thapar V, Hochberg FH, Sequist LV, Nahed BV, S Carter B, Toner M, Balaj L, T Ting D, Breakefield XO, Stott SL.
Journal:Nat Commun. 2018 Jan 12;9(1):175.
Description:Tumor-derived EVs have the potential to be utilized as disease-specific biomarkers, and genes specific to GBM as well as transcripts that are hallmarks for the four genetic subtypes of the disease.